These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1704168)

  • 41. Steady-state plasma concentrations of propafenone--chirality and metabolism.
    Volz M; Mitrovic V; Schlepper M
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):370-5. PubMed ID: 7952800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
    Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
    Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
    Ito S; Gow R; Verjee Z; Giesbrecht E; Dodo H; Freedom R; Tonn GR; Axelson JE; Zalzstein E; Rosenberg HC; Koren G
    J Clin Pharmacol; 1998 Jun; 38(6):496-501. PubMed ID: 9650538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Propafenone: a new antiarrhythmic agent.
    Chow MS; Lebsack C; Hilleman D
    Clin Pharm; 1988 Dec; 7(12):869-77. PubMed ID: 3061720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quinidine in elderly patients.
    Simon AP
    Am Fam Physician; 1974 May; 9(5):127-31. PubMed ID: 4133376
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine].
    Pelosi G; Duca G; Bareggi SR; Pirola R; Hadëri B
    G Ital Cardiol; 1993 Aug; 23(8):777-86. PubMed ID: 8119501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
    Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
    Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
    [No Abstract]   [Full Text] [Related]  

  • 54. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
    G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
    de Brito FS; Pereira MH; Castro I; Maia IG
    Arq Bras Cardiol; 1979 Oct; 33(4):303-10. PubMed ID: 94993
    [No Abstract]   [Full Text] [Related]  

  • 57. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
    Stec S; Sikorska A; Zaborska B; Kryński T; Szymot J; Kułakowski P
    Kardiol Pol; 2012; 70(4):351-8. PubMed ID: 22528707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of propafenone, quinidine, and their combination on ventricular fibrillation threshold in dogs].
    Lu F; Zhang XM; Mei BY
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):364-7. PubMed ID: 1456063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG; Zaim S; Saroff AL; Kirschenbaum M
    Am J Cardiol; 1987 Sep; 60(7):584-9. PubMed ID: 2442993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.